NTI vs PHX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

NTI

NEUROTECH FPO [NTI]

42LOW

PHX

PHARMX FPO [PHX]

42LOW

Score Breakdown

NTI PHX
Technical
79
57
Catalyst
53
51
Sentiment
50
50
Fundamental
67
66
Momentum
60
55
Risk Gate
31
50

Key Metrics

NTI Metric PHX
$23.7MMarket Cap$79.1M
2.7MAvg Volume (20d)448K
N/AShort InterestN/A
$0.02952-Week High$0.200
$0.01052-Week Low$0.084
+12.5%Daily Change+0.0%
$0.018Entry Price$0.120
-66.3%ROE-5.9%
-54.4%Profit Margin-12.2%

Active Signals

NTI Signals

●MACD momentum is picking up steam
●Trading above both moving averages — the trend is your friend here
●Volume surging at 2.9x normal while price falls — heavy selling pressure
●Just broke above 20-day resistance — a level that was capping price, now cleared
●On a tear — up 12.5% over the last 5 days
●Beating the Small Ords index — relative strength of 1.21, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (9 quarters)

PHX Signals

●Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Moderate P/S ratio (10.3x)
●Small-cap ($20-100M)
●Capital raise activity (1 events)
●CANSLIM S: Tight float (41%)
●Negative profit margins (-12%)

Ask Scout AI to compare NTI and PHX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
NTI Full Analysis → PHX Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).